Literature DB >> 33686350

Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine.

Lenka Koklesova1, Marek Samec1, Alena Liskova1, Kevin Zhai2, Dietrich Büsselberg2, Frank A Giordano3, Peter Kubatka4, Olga Golunitschaja5.   

Abstract

Mitochondrial injury plays a key role in the aetiopathology of multifactorial diseases exhibiting a "vicious circle" characteristic for pathomechanisms of the mitochondrial and multi-organ damage frequently developed in a reciprocal manner. Although the origin of the damage is common (uncontrolled ROS release, diminished energy production and extensive oxidative stress to life-important biomolecules such as mtDNA and chrDNA), individual outcomes differ significantly representing a spectrum of associated pathologies including but not restricted to neurodegeneration, cardiovascular diseases and cancers. Contextually, the role of predictive, preventive and personalised (PPPM/3P) medicine is to introduce predictive analytical approaches which allow for distinguishing between individual outcomes under circumstance of mitochondrial impairments followed by cost-effective targeted prevention and personalisation of medical services. Current article considers innovative concepts and analytical instruments to advance management of mitochondriopathies and associated pathologies.
© The Author(s) 2021.

Entities:  

Keywords:  Aetiopathology multi-organ dysfunction; Ageing; Alzheimer; Biomarker panel; COVID-19; Cancer; Cardiovascular disease; Complementary medicine; Cost efficacy; Energy imbalance; Glaucoma; Health policy; Individualised patient profiling; Injury; Liquid biopsy; Mechanisms; Mitigating measures; Mitochondrial impairment; Molecular patterns; Multi-modal diagnostics; Multifactorial disease; Neurodegeneration; Origin; Outcomes; Oxidative stress; Patient stratification; Predictive preventive personalised medicine (PPPM/3PM); ROS; Repair; Reversible damage; Suboptimal health; Vasospasm; Vicious circle

Year:  2021        PMID: 33686350      PMCID: PMC7931170          DOI: 10.1007/s13167-021-00237-2

Source DB:  PubMed          Journal:  EPMA J        ISSN: 1878-5077            Impact factor:   6.543


  8 in total

1.  Rapid triage for ischemic stroke: a machine learning-driven approach in the context of predictive, preventive and personalised medicine.

Authors:  Yulu Zheng; Zheng Guo; Yanbo Zhang; Jianjing Shang; Leilei Yu; Ping Fu; Yizhi Liu; Xingang Li; Hao Wang; Ling Ren; Wei Zhang; Haifeng Hou; Xuerui Tan; Wei Wang
Journal:  EPMA J       Date:  2022-05-27       Impact factor: 8.836

Review 2.  Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine.

Authors:  Lenka Koklesova; Alena Mazurakova; Marek Samec; Erik Kudela; Kamil Biringer; Peter Kubatka; Olga Golubnitschaja
Journal:  EPMA J       Date:  2022-05-12       Impact factor: 8.836

Review 3.  Parkinson's Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment.

Authors:  Aurelian Anghelescu; Gelu Onose; Cristina Popescu; Mihai Băilă; Simona Isabelle Stoica; Ruxandra Postoiu; Elena Brumă; Irina Raluca Petcu; Vlad Ciobanu; Constantin Munteanu
Journal:  Biomedicines       Date:  2022-04-26

Review 4.  Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine.

Authors:  Siqi Wen; Chunling Li; Xianquan Zhan
Journal:  EPMA J       Date:  2022-02-17       Impact factor: 6.543

5.  Early gestational profiling of oxidative stress and angiogenic growth mediators as predictive, preventive and personalised (3P) medical approach to identify suboptimal health pregnant mothers likely to develop preeclampsia.

Authors:  Enoch Odame Anto; David Antony Coall; Otchere Addai-Mensah; Yaw Amo Wiafe; William K B A Owiredu; Christian Obirikorang; Max Efui Annani-Akollor; Eric Adua; Augustine Tawiah; Emmanuel Acheampong; Evans Adu Asamoah; Xueqing Wang; Stephen Opoku; Derick Kyei Boakye; Haifeng Hou; Youxin Wang; Wei Wang
Journal:  EPMA J       Date:  2021-10-21       Impact factor: 6.543

6.  Key Characteristics of Cardiovascular Toxicants.

Authors:  Lars Lind; Jesus A Araujo; Aaron Barchowsky; Scott Belcher; Brian R Berridge; Nipavan Chiamvimonvat; Weihsueh A Chiu; Vincent J Cogliano; Sarah Elmore; Aimen K Farraj; Aldrin V Gomes; Cliona M McHale; Kathleen B Meyer-Tamaki; Nikki Gillum Posnack; Hugo M Vargas; Xi Yang; Lauren Zeise; Changcheng Zhou; Martyn T Smith
Journal:  Environ Health Perspect       Date:  2021-09-24       Impact factor: 9.031

Review 7.  Potentiating the Benefits of Melatonin through Chemical Functionalization: Possible Impact on Multifactorial Neurodegenerative Disorders.

Authors:  Annia Galano; Eduardo G Guzmán-López; Russel J Reiter
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

8.  Superficial temperature distribution patterns before and after physical activity in school children are indicative for personalized exercise coaching and disease prevention.

Authors:  Agnieszka Dębiec-Bąk; Anna Skrzek; Halina Podbielska; Olga Golubnitschaja; Małgorzata Stefańska
Journal:  EPMA J       Date:  2021-11-05       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.